Jonathan I. Lieber - Jun 7, 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Jun 7, 2022
Transactions value $
$7,016
Form type
4
Date filed
6/8/2022, 03:12 PM
Previous filing
Jan 21, 2022
Next filing
Aug 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $7.02K +37.5K $0.19 37.5K Jun 7, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.